Type 1 diabetes mellitus with hyperglycemia
ICD-10 E10.65 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with hyperglycemia.
Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterized by the destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Patients with T1DM often present with symptoms such as polyuria, polydipsia, and unexplained weight loss. Hyperglycemia, defined as elevated blood glucose levels, is a common complication of diabetes and can occur due to inadequate insulin management, dietary indiscretion, or illness. Chronic hyperglycemia can lead to serious complications, including diabetic ketoacidosis (DKA), cardiovascular disease, neuropathy, nephropathy, and retinopathy. Management of T1DM typically involves a combination of insulin therapy, dietary modifications, and regular monitoring of blood glucose levels. The HbA1c test is a critical tool for assessing long-term glycemic control, with target levels generally set below 7% for most adults. However, individual goals may vary based on patient-specific factors. Effective management of T1DM and associated hyperglycemia requires a multidisciplinary approach, including education on insulin administration, carbohydrate counting, and recognition of hypoglycemia and hyperglycemia symptoms.
Detailed records of insulin therapy, HbA1c levels, and patient education on diabetes management.
Patients presenting with uncontrolled blood glucose levels, frequent DKA episodes, or complications such as neuropathy.
Endocrinologists must document the rationale for insulin adjustments and any changes in treatment plans.
Comprehensive patient history, including lifestyle factors, medication adherence, and regular monitoring of blood glucose levels.
Routine follow-ups for diabetes management, addressing acute hyperglycemia, and coordinating care with specialists.
Primary care providers should ensure continuity of care and document referrals to specialists when necessary.
Used for routine follow-up visits for diabetes management.
Documentation must include patient history, examination findings, and management plan.
Endocrinologists may require more detailed documentation of treatment adjustments.
E10.65 is used when a patient with Type 1 diabetes has hyperglycemia, while E10.9 is used for Type 1 diabetes without complications. Accurate coding depends on the presence of hyperglycemia and its management.
